title: Tandem triplication of the BCL2 gene in CD5-positive intravascular large B cell lymphoma with bone marrow involvement.
authors.affiliation: Division of Medical Oncology/Hematology, Department of Medicine, Graduate School of Medicine, Kobe University, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan, kyamamo@med.kobe-u.ac.jp.
authors.forename: Katsuya
authors.initials: K
authors.lastname: Yamamoto
authors.forename: Atsuo
authors.initials: A
authors.lastname: Okamura
authors.forename: Kimikazu
authors.initials: K
authors.lastname: Yakushijin
authors.forename: Yoshitake
authors.initials: Y
authors.lastname: Hayashi
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Matsuoka
authors.forename: Hironobu
authors.initials: H
authors.lastname: Minami
mesh_terms: D000369:Aged, 80 and over; D000782:Aneuploidy; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D002869:Chromosome Aberrations; D020223:Chromosome Painting; D002887:Chromosomes, Human, Pair 18 / Q000235:genetics; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D017809:Fatal Outcome; D005260:Female; D005784:Gene Amplification; D019254:Genes, bcl-2; D006801:Humans; D007399:Interphase; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000235:genetics*; D008677:Metaphase; D011241:Prednisone / Q000008:administration & dosage; D000069283:Rituximab; D014178:Translocation, Genetic; D014314:Trisomy / Q000235:genetics*; D019043:Vascular Neoplasms / Q000188:drug therapy / Q000235:genetics*; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone